What is Driving the Growth of the Oxygen Therapy Market?
The oxygen therapy market has gained significant attention as demand for advanced respiratory care rises worldwide. With increasing cases of chronic respiratory illnesses, sleep apnea, pneumonia, and asthma, oxygen therapy solutions have become essential in hospitals, clinics, and homecare settings. In 2024, the global oxygen therapy market was valued at USD 37.20 billion, and it is projected to grow at a CAGR of 6.83% from 2025 to 2034, reaching USD 72.02 billion by 2034. This growth is strongly supported by government initiatives, technological innovations, and rising awareness about the benefits of oxygen therapy in improving patient outcomes.
Oxygen Therapy Market Size and Growth Outlook
The rapid expansion of the oxygen therapy market is linked to several factors:
- Increasing cases of chronic obstructive pulmonary disease (COPD) and sleep apnea
- Post-pandemic awareness of respiratory health
- Rising geriatric population requiring long-term oxygen support
- Introduction of portable and advanced oxygen delivery devices
Governments in both developed and emerging economies have been offering incentives and subsidies to expand access to oxygen concentrators, cylinders, and liquid oxygen systems, particularly in underserved regions. This is not only fueling adoption but also boosting investments from healthcare companies and technology providers.
Oxygen Therapy Market Breakup by Product
Oxygen Source Equipment
Oxygen source equipment forms the backbone of oxygen therapy. The segment includes liquid oxygen devices, oxygen cylinders, and oxygen concentrators. Among these, concentrators have gained traction for their efficiency and convenience, especially in homecare settings. Liquid oxygen devices continue to be preferred in hospital environments due to their ability to store larger volumes.
The rising demand for reliable oxygen supply during emergencies has also accelerated adoption in ambulatory surgical centers and clinics. Companies are investing in lighter, more energy-efficient devices, making oxygen therapy more accessible for both stationary and portable use.
PAP Devices
Positive Airway Pressure (PAP) devices play a major role in managing obstructive sleep apnea and other respiratory disorders. The segment includes CPAP, APAP, and Bi-PAP machines. With the growing awareness of sleep-related conditions, PAP devices have seen strong growth. CPAP machines dominate in terms of adoption, while APAP and Bi-PAP machines are growing quickly due to their adaptability and advanced control features.
Oxygen Delivery Devices
Oxygen delivery devices such as oxygen masks, venturi masks, bag-valve masks, non-breather masks, and nasal cannulas are essential across clinical and emergency care. Nasal cannulas remain widely used due to patient comfort, while non-breather masks are crucial in critical care settings. Innovations in design are focused on improving patient compliance and reducing skin irritation during prolonged use.
Oxygen Therapy Market Breakup by Portability
Stationary Devices
Stationary oxygen therapy systems are primarily used in hospitals and long-term care facilities. They provide stable and high-capacity oxygen supply, which is crucial for patients with chronic conditions requiring continuous oxygen flow.
Portable Devices
Portable devices are driving the biggest transformation in the oxygen therapy market. They provide patients with mobility and independence, especially those with COPD or cystic fibrosis. The demand for portable concentrators has risen as homecare adoption grows, with patients preferring devices that support travel and active lifestyles.
Oxygen Therapy Market Breakup by Application
Asthma
Asthma patients benefit from controlled oxygen delivery during acute attacks. With global asthma prevalence increasing, especially among children and the elderly, this segment is witnessing steady growth.
Pneumonia
Pneumonia treatment often requires oxygen supplementation to maintain blood oxygen levels. The rise of community-acquired pneumonia cases in emerging economies has highlighted the importance of accessible oxygen therapy devices.
Cystic Fibrosis
Cystic fibrosis management requires long-term oxygen support. The availability of portable oxygen solutions is improving the quality of life for patients dealing with this chronic condition.
Respiratory Distress Syndrome
Respiratory distress syndrome in infants and adults demands immediate oxygen therapy. With neonatal care advancing, specialized oxygen delivery equipment for infants has seen higher demand in hospitals.
Obstructive Sleep Apnea
Oxygen therapy combined with PAP devices has become a cornerstone in sleep apnea management. The increasing diagnosis of this condition is boosting sales of CPAP and Bi-PAP devices globally.
Chronic Obstructive Pulmonary Disease (COPD)
COPD remains the largest application segment for oxygen therapy. The global rise in smoking, pollution, and aging populations has made COPD one of the leading causes of death, driving oxygen therapy adoption worldwide.
Oxygen Therapy Market Breakup by End User
Hospitals and Clinics
Hospitals continue to account for the largest share of oxygen therapy demand due to the need for acute and emergency care. Clinics also contribute significantly, particularly for managing chronic respiratory conditions.
Ambulatory Surgical Centers (ASCs)
ASCs are adopting oxygen therapy devices to manage patients undergoing outpatient procedures. Compact and portable oxygen systems have enabled greater use in these facilities.
Homecare Settings
Homecare is the fastest-growing segment, driven by patient preference for comfort and cost savings. Portable oxygen concentrators and PAP devices are in high demand in this category.
From Seed to Sale: Inside the Oxygen Therapy Market
Explore innovations, expansion trends, and global opportunities in this free expert report.
Oxygen Therapy Market Breakup by Region
North America
North America leads the market due to advanced healthcare infrastructure, high prevalence of COPD and sleep apnea, and government reimbursement policies supporting oxygen therapy.
Europe
Europe shows strong demand for both stationary and portable oxygen devices. Stringent regulations around medical device safety have spurred continuous innovation in this region.
Asia Pacific
Asia Pacific is expected to witness the fastest growth. Factors include a large patient base, rising healthcare investments, and increasing awareness of respiratory health post-COVID-19.
Latin America
Latin America is seeing growth in hospital demand and government-led programs to increase oxygen availability in rural areas.
Middle East and Africa
The Middle East and Africa region face challenges with healthcare infrastructure but is increasingly focusing on portable oxygen solutions to address rising cases of respiratory distress and COPD.
Key Players in the Oxygen Therapy Market
Leading companies in the oxygen therapy industry are focusing on product innovation, partnerships, and expanding global distribution. Notable players include:
- Philips Healthcare – A leader in PAP devices and homecare oxygen therapy solutions.
- Linde Healthcare – Strong in hospital-based oxygen supply and industrial gas applications.
- Chart Industries, Inc. – Known for liquid oxygen devices and cryogenic solutions.
- Invacare Corporation – Focused on portable oxygen concentrators and mobility solutions.
- Smith Pharmacy – A regional player catering to oxygen delivery needs.
- Dragerwerk AG & Co. KGaA – Specializes in advanced oxygen masks and ventilatory support systems.
- Teleflex Incorporated – Known for respiratory disposables and oxygen delivery devices.
- Fisher & Paykel Healthcare Corporation Limited – Innovator in nasal cannulas and patient comfort-focused designs.
FAQs
Q1: What is the current size of the oxygen therapy market?
The global oxygen therapy market was valued at USD 37.20 billion in 2024 and is expected to reach USD 72.02 billion by 2034, growing at a CAGR of 6.83%.
Q2: How is the oxygen therapy market growing worldwide?
The market is expanding due to rising cases of chronic respiratory diseases, increasing demand for homecare oxygen therapy, and technological advancements in portable devices.
Q3: Which oxygen therapy products are in highest demand?
Oxygen concentrators, CPAP devices, and nasal cannulas remain the most widely used products due to their accessibility and efficiency.
Q4: Which region is expected to dominate the oxygen therapy market?
North America currently dominates the market, while Asia Pacific is projected to record the fastest growth during 2025–2034.
Q5: Who are the major players in the oxygen therapy market?
Key players include Philips Healthcare, Linde Healthcare, Invacare Corporation, Chart Industries, Dragerwerk, Teleflex, Smith Pharmacy, and Fisher & Paykel Healthcare.
Find More Reports
Osteoarthritis Therapeutics Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
